Menu
Hepatitis latest research
In response to the World Health Organization's current focus on treating hepatitis and reducing infections worldwide, Dove Medical Press has compiled the latest research on hepatitis and hepatocellular carcinoma across our portfolio of journals. Thank you to our community of authors and peer reviewers who continue to contribute to the campaign against this disease.
This content is free to access and updated daily.
- 254 records -
PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration
Gong Y, Zhou M, Zhu Y, Pan J, Zhou X, Jiang Y, Zeng H, Zheng H, Geng X, Huang D
Journal of Hepatocellular Carcinoma 2024, 11:813-838
Published Date: 8 May 2024
Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion
Yu Y, Wang XH, Hu WJ, Chen DH, Hu ZL, Li SQ
Journal of Hepatocellular Carcinoma 2024, 11:801-812
Published Date: 8 May 2024
Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine
Younis MA, Harashima H
Pharmacogenomics and Personalized Medicine 2024, 17:193-213
Published Date: 7 May 2024
Negative Impact of Intra-Operative Blood Transfusion on Survival Outcomes of Hepatocellular Carcinoma Patients
Teng L, Zhao L, Shao H, Dai J, Zou H
Cancer Management and Research 2024, 16:385-393
Published Date: 25 April 2024
Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study
Hu Z, Zhou H
Journal of Hepatocellular Carcinoma 2024, 11:767-774
Published Date: 24 April 2024
A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation
Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z
Journal of Hepatocellular Carcinoma 2024, 11:747-766
Published Date: 23 April 2024
Construction of an Immunogenic Cell Death-Related Gene Signature and Genetic Subtypes for Predicting Prognosis, Immune Microenvironments, and Drug Sensitivity in Hepatocellular Carcinoma
Li S, Zhang T, Sun X, Li X
Journal of Inflammation Research 2024, 17:2427-2444
Published Date: 22 April 2024
Synchronous Double Primary Tumors of Liver (Small Cell Neuroendocrine Carcinoma and Hepatocellular carcinoma): A Case Report
Bu Y, Wen J, Wang F, Dong S, He L, Li Y, Liang J, Zhang H
Hepatic Medicine: Evidence and Research 2024, 16:31-36
Published Date: 20 April 2024
Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y
Journal of Hepatocellular Carcinoma 2024, 11:737-746
Published Date: 18 April 2024
Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study
Huang H, Liao W, Zhang K, Wang H, Cheng Q, Mei B
Journal of Hepatocellular Carcinoma 2024, 11:721-735
Published Date: 8 April 2024
Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy
Xie D, Li Z, Yuan J, Yin X, Chen R, Zhang L, Ren Z
Journal of Hepatocellular Carcinoma 2024, 11:693-705
Published Date: 4 April 2024
High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization
Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D
Journal of Hepatocellular Carcinoma 2024, 11:651-663
Published Date: 27 March 2024
Induction of Hepatocellular Carcinoma in Conventional Domestic Swine Using N-Diethylnitrosamine and Phenobarbital
Giselvania A, Juniantito V, Wibowo H, Siregar TP, Gondhowiardjo S
Cancer Management and Research 2024, 16:245-257
Published Date: 25 March 2024
The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients
Ma X, Sun X, Xie F, Jian W, Wang Q, Xie Y, Li C, Zhang K
Journal of Hepatocellular Carcinoma 2024, 11:619-628
Published Date: 25 March 2024
Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro
Du YQ, Yuan B, Ye YX, Zhou FL, Liu H, Huang JJ, Wei YF
Journal of Hepatocellular Carcinoma 2024, 11:565-580
Published Date: 19 March 2024
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, Li G
Journal of Hepatocellular Carcinoma 2024, 11:581-594
Published Date: 19 March 2024
Efficacy and Safety of Hepatic Arterial Infusion Therapy with Cinobufacini in Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Retrospective Cohort Study
Xue T, Yu H, Feng W, Wang Y, Wu S, Wang L, Zhu P, Guan J, Sun Q
Cancer Management and Research 2024, 16:163-175
Published Date: 14 March 2024
A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
Zong S, Huang G, Pan B, Zhao S, Ling C, Cheng B
Journal of Hepatocellular Carcinoma 2024, 11:525-542
Published Date: 12 March 2024
LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma
Wei H, Wu X, Huang L, Long C, Lu Q, Huang Z, Huang Y, Li W, Pu J
Journal of Hepatocellular Carcinoma 2024, 11:543-562
Published Date: 11 March 2024
Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation
Shan L, Zhao N, Wang F, Zhai D, Liu J, Lv X
Journal of Inflammation Research 2024, 17:1589-1605
Published Date: 11 March 2024
Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation
Zhang BL, Liu J, Diao G, Chang J, Xue J, Huang Z, Zhao H, Yu L, Cai J
Journal of Hepatocellular Carcinoma 2024, 11:489-508
Published Date: 6 March 2024
A Deep Learning Model Combining Multimodal Factors to Predict the Overall Survival of Transarterial Chemoembolization
Sun Z, Li X, Liang H, Shi Z, Ren H
Journal of Hepatocellular Carcinoma 2024, 11:385-397
Published Date: 26 February 2024
Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment
Liang Y, Zhong D, Yang Q, Tang Y, Qin Y, Su Y, Huang X, Shang J
Journal of Hepatocellular Carcinoma 2024, 11:373-383
Published Date: 22 February 2024
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?
Himmelsbach V, Koch C, Trojan J, Finkelmeier F
Journal of Hepatocellular Carcinoma 2024, 11:363-372
Published Date: 19 February 2024
Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia
Alolyan A, Alshammari K, Arabi M, Alshehri A, Alsuhaibani H, Ibnshamsah F, Alsharm A, Mahrous M, Al Zanbagi A, Hassanain M, Bazarbashi S
Journal of Hepatocellular Carcinoma 2024, 11:349-362
Published Date: 16 February 2024
Lipid Metabolism as a Potential Target of Liver Cancer
Wu K, Lin F
Journal of Hepatocellular Carcinoma 2024, 11:327-346
Published Date: 14 February 2024
C-Reactive Protein-Albumin Ratio (CAR): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Curative Hepatectomy for Hepatocellular Carcinoma
Mai RY, Lu TL, Lu RJ, Zeng C, Lian F, Li LQ, Wu GB, Ye JZ
Journal of Inflammation Research 2024, 17:919-931
Published Date: 12 February 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J
Journal of Hepatocellular Carcinoma 2024, 11:305-316
Published Date: 8 February 2024
Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States
Bteich F, Desai K, Zhang C, Kaur A, Levy RA, Bioh L, Wang A, Sultana S, Kaubisch A, Kinkhabwala M, Bellemare S, Fidvi S, Kanmaniraja D, Berkenblit R, Moon JY, Adedimeji A, Tow CY, Saenger Y
Journal of Hepatocellular Carcinoma 2024, 11:257-269
Published Date: 3 February 2024
Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation
Qiao W, Li J, Wang Q, Jin R, Zhang H
Journal of Hepatocellular Carcinoma 2024, 11:271-284
Published Date: 3 February 2024
Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma
Qiu X, Dong L, Wang K, Zhong X, Xu H, Xu S, Guo H, Wei X, Chen W, Xu X
Journal of Hepatocellular Carcinoma 2024, 11:241-255
Published Date: 2 February 2024
Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular Carcinoma
Zhang C, Tao Y, Yang R, Wang Y, Yu Y, Zhou Y
Journal of Hepatocellular Carcinoma 2024, 11:229-240
Published Date: 26 January 2024
A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy
Yang H, Lu L, Guo W, Gong B, Wang X, Chen Y, Chen X
Journal of Hepatocellular Carcinoma 2024, 11:219-228
Published Date: 25 January 2024
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy
Yang H, Cong T, Luo Y, Yang C, Ren J, Li X
Journal of Hepatocellular Carcinoma 2024, 11:175-189
Published Date: 24 January 2024
A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study
Wang H, Chen JJ, Yin SY, Sheng X, Wang HX, Lau WY, Dong H, Cong WM
Journal of Hepatocellular Carcinoma 2024, 11:191-206
Published Date: 24 January 2024
The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma
Mai Y, Meng L, Deng G, Qin Y
Journal of Hepatocellular Carcinoma 2024, 11:159-171
Published Date: 19 January 2024
Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma
Wang Z, Kong L, Zhang R, Yang X, Cao Z, Xu T, Zhang H, Dou Y
Journal of Hepatocellular Carcinoma 2024, 11:131-143
Published Date: 16 January 2024
Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation
Qiao W, Fan Z, Wang Q, Jin R, Hu C
Journal of Hepatocellular Carcinoma 2024, 11:65-79
Published Date: 13 January 2024
Novel Preoperative Type IV Collagen to Predict the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Cirrhotic Portal Hypertension After Laparoscopic Splenectomy and Azygoportal Disconnection
Gao TM, Jin SJ, Fang F, Qian JJ, Zhang C, Zhou BH, Bai DS, Jiang GQ
Journal of Hepatocellular Carcinoma 2023, 10:2411-2420
Published Date: 12 January 2024
PD1 and TIM3 Expression is Associated with Very Early Hepatocellular Carcinoma Recurrence After Percutaneous Thermal Ablation
Ghelfi J, Macek Jilkova Z, Sengel C, Brusset B, Teyssier Y, Costentin C, Mercey-Ressejac M, Dumolard L, Manceau M, Mathieu E, Bricault I, Decaens T
Journal of Hepatocellular Carcinoma 2024, 11:39-50
Published Date: 9 January 2024
Pencil Beam Scanning Carbon Ion Radiotherapy for Hepatocellular Carcinoma
Zhang W, Cai X, Sun J, Wang W, Zhao J, Zhang Q, Jiang G, Wang Z
Journal of Hepatocellular Carcinoma 2023, 10:2397-2409
Published Date: 29 December 2023
Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma
Wei Q, Hou YC, Mao FF, Feng JK, Wang X, Cheng SQ
Hepatic Medicine: Evidence and Research 2023, 15:249-264
Published Date: 27 December 2023
Surgical Strategies Affect the Long-Term Prognosis of Patients with Hepatocellular Carcinoma Adjacent to the Left Branch of the Portal Vein
Bai S, Shen X, Liu J, Lu C, Wang J, Liu L, Wang C, Wang H, Liu K, Sun Y, Xue F
Journal of Hepatocellular Carcinoma 2023, 10:2355-2366
Published Date: 27 December 2023
Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients
Wang X, Yu Y, Tao Y, Wang Y, Zhang C, Cui Y, Zhou Y
Journal of Hepatocellular Carcinoma 2023, 10:2323-2335
Published Date: 21 December 2023
Epidemiology of Hepatitis B in Saudi Arabia from 2006 to 2021
Alghamdi IG, Alghamdi RM, Alghamdi MS, Alghamdi AM, Alghamdi MI, Alghamdi ZI, Alghamdi KS
Hepatic Medicine: Evidence and Research 2023, 15:233-247
Published Date: 21 December 2023
The Prognostic Significance of the TEAD4 in Hepatocellular Carcinoma
Lei L, Yang J, Peng H, Huang R, Liang L, Liu R, Li J
International Journal of General Medicine 2023, 16:6005-6013
Published Date: 20 December 2023
Predicting T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma Based on Dynamic Contrast-Enhanced Ultrasound Radiomics
Wang Y, Weng W, Liang R, Zhou Q, Hu H, Li M, Chen L, Chen S, Peng S, Kuang M, Xiao H, Wang W
Journal of Hepatocellular Carcinoma 2023, 10:2291-2303
Published Date: 18 December 2023
Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Hoang TPT, Schindler P, Börner N, Masthoff M, Gerwing M, von Beauvais P, De Toni EN, Lange CM, Trebicka J, Morgül H, Seidensticker M, Ricke J, Pascher A, Guba M, Ingrisch M, Wildgruber M, Öcal O
Journal of Hepatocellular Carcinoma 2023, 10:2277-2289
Published Date: 18 December 2023
An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma
Peng Y, Wu X, Zhang Y, Yin Y, Chen X, Zheng D, Wang J
Journal of Hepatocellular Carcinoma 2023, 10:2305-2321
Published Date: 18 December 2023
Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Gao B, Yang F, Zheng D, Hu S, Liu J, Liu H, Liu Y, Liu L, Wang R, Zhao Y, Cui C, Fang C, Yang J, Su S, Han Y, Yang X, Li B
Journal of Hepatocellular Carcinoma 2023, 10:2265-2276
Published Date: 13 December 2023